Imbed Biosciences is an emerging leader in the design, development, and manufacture of cutting edge and advanced devices for soft tissues, burns, and ulcers.2 The fundamental premise and passion at Imbed Biosciences, is to build and provide unique and novel products that are designed to contain a precise combination of three key healing elements: a fully synthetic and biocompatible matrix, a non-toxic and broad-spectrum antimicrobial benefit, and assistance in maintaining optimal moisture balance in the healing environment.2,3,4
Each product line offered by Imbed Biosciences is specifically and uniquely formulated to improve outcomes in high-risk Surgical Wounds – aid in the management of 1st or 2nd Degree Burns – or to assist in the healing of Ulcers.
Imbed Biosciences Inc. is a privately held medical device company emerging as a leader in the development of advanced devices for the treatment of burns, ulcers, and soft-tissue repair. The company has a portfolio of products based on its patented technology. Imbed Biosciences is registered with U.S. FDA as a medical device manufacturer and maintains an ISO 13485 certified Quality Management System.
Madison, WI, October 4, 2021 – Imbed Biosciences, Inc. (Imbed), a privately held biotech company emerging as a leader in advanced wound care, announced today the results of a prospective